Xinkanghe Biopharma (鑫康合生物医药)
浙江鑫康合生物医药科技有限公司-创新性组合的药物开发
Founded 2015 · $16.6M raised
- Founded
- 2015
- Business Model
- B2B
- Website
- kanovabiopharma.com
- Total Funding
- $16.6M
- Last Round
- $16.6M Series A
- Rounds
- 1
About
Develops drugs for novel targets/combinations in oncology and autoimmune inflammatory disease
Summary
Xinkanghe Biopharma (鑫康合生物医药) is a Biotech company, founded in 2015. It has raised $16.6M in total across 1 round. Investors include Northern Light Ventures.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Unknown
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/xinkanghe-biopharma"><img src="https://indexed.vc/api/badge/company/xinkanghe-biopharma" alt="Xinkanghe Biopharma (鑫康合生物医药) on Indexed.vc" width="260" height="76" /></a>